Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer

Shranjeno v:

Bibliografske podrobnosti
izdano v:	Nature Reviews. Clinical Oncology vol. 22, no. 8 (Aug 2025), p. 546
Glavni avtor:	Tang, Li-Bo
Drugi avtorji:	Peng, Ying-Long, Chen, Ji, Li, Jia-Ting, Zheng, Mei-Mei, Wu, Lv, Lu, Chang, Wei, Xue-Wu, Cai, Dong-Xuan, Guo, Zhi, Ren, Zi-Rui, Lv, Si-Di, Deng, Yu, Chen, Zhi-Hong, Xu, Chong-Rui, Zhou, Qing
Izdano:	Nature Publishing Group
Teme:	T cell receptors Patients Small cell lung carcinoma Metastasis Lung cancer Antibodies Immunotherapy Immune checkpoint inhibitors Cancer therapies Non-small cell lung carcinoma Lymphocytes Ligands Antigens Chemotherapy Remission Signal transduction
Online dostop:	Citation/Abstract
Oznake:	Označite Brez oznak, prvi označite!